ABBV - AbbVie Inc News - CNNMoney.com

43.54 Data as of Jun 18	+0.53 / +1.23% Today’s Change	32.51 Today\|\|\|52-Week Range 48.00	+27.46% Year-to-Date

About CNNMoney
Content
Magazines
Site Tools
Stay Connected
- My Account
- Mobile Site & Apps
- Facebook
- Twitter
- LinkedIn
- YouTube
- RSS Feeds
- Newsletters
- Tumblr
- Google+

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones Indexes^SM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones Indexes^SM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.

"Pay-For Delay" Was Fun While It Lasted Jun 18 / MotleyFool.com	Encouraging Data from Bristol-Myers - Analyst Blog Jun 13 / Zacks.com
Pharma payments to delay generic rivals to be scrutinised Jun 17 / FT.com	Label Expansion for Roche's RoActemra - Analyst Blog Jun 12 / Zacks.com
Abbott Loves Abbott Laboratories Stock Jun 17 / MotleyFool.com	2 More Good Reasons to Buy Celgene Jun 12 / MotleyFool.com
American Generics Can't Touch This $8 Billion Drug (Yet) Jun 17 / MotleyFool.com	New Data Improves Sales Outlook For Celgene's Apremilast Jun 12 / TheStreet.com
Data on BMY/ AbbVie's elotuzumab - Analyst Blog Jun 17 / Zacks.com	Pipeline Progress at Roche - Analyst Blog Jun 10 / Zacks.com
AbbVie Issues Prelim. Results from Phase I Study of ABT-199/GDC-0199 for High-Risk CL... Jun 17 / Benzinga	Is This GlaxoSmithKline's Next Big Blockbuster? Jun 07 / MotleyFool.com
Johnson & Johnson's Gut Feeling About the Future of Medicine Jun 14 / MotleyFool.com	Here's What This $5 Billion Hedge Fund Has Been Buying Jun 06 / MotleyFool.com
Abbott Progresses with Absorb in Japan - Analyst Blog Jun 14 / Zacks.com	Revlimid Gains, Celgene Loses Jun 05 / MotleyFool.com
New Data on UCB's Cimzia - Analyst Blog Jun 14 / Zacks.com	Generic drugs: Watchdogs probe pay-for-delay deals May 28 / FT.com
Positive Data on Incyte/LLY's Baricitinib - Analyst Blog Jun 14 / Zacks.com	US doctors paid $1bn by top drug companies May 22 / FT.com
Mid-Morning Market Update: Markets Rise, Gannett To Acquire Belo For $1.5B Jun 13 / Benzinga	Excerpt From My Daily Journal Entry May 20 / StockTwits

AbbVie Inc (NYSE:ABBV)

Latest ABBV News | Press Releases

To view my watchlist

Search for jobs

Search All Jobs from Across the Web